ArticleCommunications medicine2025

Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes.

Avia D Wilkerson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.